Improv Music Therapy for Older Adults

February 20, 2026 updated by: University of California, San Francisco

Impact of Improvisation Music Therapy for Persons Living With Dementia and Their Care Partners

Older adults and their care partners will participate in music therapy sessions for approximately 8 weeks. Before and after the 8 week study period, participants will fill out questionnaires about their mood, stress levels, and emotions. During the music therapy sessions, they may be observed or asked questions about the music therapy sessions.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • San Francisco, California, United States, 94158
        • University of California, San Francisco

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

Inclusion criteria for the Person Living with Dementia (PLWD) are:

  • Age 60 and over, living independently in the community
  • Medical diagnosis of Alzheimer's Disease
  • Mild dementia defined as MoCA score between 16-20, or MMSE score between 19-24
  • Sufficient visual and hearing acuity (age-related to normal hearing loss with assistive devices)
  • English fluency rated fairly well to well (self-rated English fluency)

Inclusion Criteria for Caregiver are:

  • Age 18 or Older
  • Moderate to good English fluency (self-rated English fluency)
  • Willing to participate in intervention with PLWD

Exclusion Criteria

Exclusion criteria for PLWD are:

  • Medical diagnosis of severe dementia (any etiology)
  • Non-AD dementia diagnosis (e.g., frontotemporal dementia)
  • Serious medical condition (e.g., an end-stage disease requiring hospice, aphasia from stroke, paralysis, brain injury) requiring active medical management that would interfere with participation in the study
  • Significant difficulty moving the hands or arms (severe arthritis, neuropathy)
  • Plans to move out of the area within six months

Exclusion criteria for Caregiver are:

  • Current but not prior severe psychiatric disorder (e.g., schizophrenia, bipolar disorder)
  • Serious medical condition (e.g., an end-stage disease requiring hospice, aphasia from stroke, paralysis, brain injury) requiring active medical management that would interfere with participation in the study
  • Plans to move out of the area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Clinical Improvisation Immediately
Clinical improvisation music therapy offered as group sessions delivered by board-certified music therapist.
Experimental: Group B
Delayed Onset Clinical improvisation
Clinical improvisation music therapy offered as group sessions delivered by board-certified music therapist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Science of Behavior Change (SOBC) Brief-COPE
Time Frame: Baseline and Post-Intervention, 8 weeks
The Brief COPE is a 28 item measure of strategies used for coping or regulating cognitions in response to stressors. The questions assess the frequency with which a person uses different coping strategies (e.g. "I've been turning to work or other activities to take my mind off strings") and the respondent gives a rating on a 5 item scale (1= I haven't been doing this at all to 4 I've been doing this a lot).
Baseline and Post-Intervention, 8 weeks
SOBC Perceived Stress Scale
Time Frame: Baseline and Post Intervention, 8 weeks
The Perceived Stress Scale ask participants about their feelings and thoughts during the last month. There are 10 items and participants are asked how often they felt orr thought a certian way (0 = never to 4 very often)
Baseline and Post Intervention, 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dementia Mood Picture Test
Time Frame: Baseline and Post Intervention, 8 weeks
Participants are given large line face drawings with large font descriptors. Participants are asked whether or not they are experiencing each mood ("Are you in a good mood?") and the intensity of the mood. The test assesses the PLWD directly but focuses on six primary moods.
Baseline and Post Intervention, 8 weeks
SOBC Positive and Negative Affect (PANAS)
Time Frame: Baseline and Post Intervention, 8 weeks
The PANAS is a 20 item self-questionnaire. Respondent is asked to read several words which describe different feelings and emotions. Applicability of the emotion is scored by respondent on a 5 point Likert Scale (1 = very slightly or not at all to 5 = extremely). Higher scores on Positive Affect items incidate greater intensity of positive emotions and higher scores on Negative Affect indicate greater intensity of negative emotions.
Baseline and Post Intervention, 8 weeks
Neuropsychiatric Inventory (NPI-Q)
Time Frame: Baseline and Post Intervention, 8 weeks
The NPI-Q is a 12-item questionnaire completed by the caregiver. Each question asks about a neuropsychiatric symptom over the previous month. The Caregiver can say "no" and go on to the next question. If the Caregiver says "yes", the caregive then rates the a) Severity of the symptoms present on a 3 point scale (1=mild to 3 = severe), and b) Distress experienced by the caregiver due to that symptom on a 5 point scale (0 = not distressing at all to 5 very distressing).
Baseline and Post Intervention, 8 weeks
Kingston Caregivers STress Scale
Time Frame: Baseline and Post-Intervention, 8 weeks
The KCSS is at 10 item questionnaire completed by a family caregiver. The questions ask caregivers to report feeling of stress surrounding specific aspects of caregiving. Caregivers respond using a 5 point scale (1 = no stress to 5 = extreme stress)
Baseline and Post-Intervention, 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karen Barrett, PhD, University of California, San Francisco

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

February 11, 2026

First Submitted That Met QC Criteria

February 11, 2026

First Posted (Actual)

February 18, 2026

Study Record Updates

Last Update Posted (Actual)

February 23, 2026

Last Update Submitted That Met QC Criteria

February 20, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer's Disease (AD)

Clinical Trials on Clinical Improvisation

Subscribe